Results 1 to 10 of about 2,270 (113)

Norethindrone Acetate in the Medical Management of Adenomyosis [PDF]

open access: yesPharmaceuticals, 2012
The role of norethindrone acetate (NA) in the management of adenomyosis was evaluated with a retrospective chart review of 28 premenopausal women between 27–49 years of age presenting with moderate to severe pelvic pain and bleeding. Bleeding and dysmenorrhea scores were analyzed using paired T-tests.
Siddhi Mankame   +4 more
openaire   +3 more sources

Colorimetric Analysis of Norethindrone, Norethindrone Acetate, and Norgestrel in Oral Contraceptives [PDF]

open access: yesJournal of AOAC INTERNATIONAL, 1970
Abstract A colorimetric method, based on reaction with blue tetrazolium, has been devised for the analysis of norethindrone, norethindrone acetate, and norgestrel. The technique is selective for these progestins, showing no interference from the estrogens ethinyl estradiol and mestranol, commonly found in oral contraceptives.
Robert V. Smith   +2 more
openaire   +1 more source

Effects of contaminants of emerging concern on Megaselia scalaris (Lowe, Diptera: Phoridae) and its microbial community. [PDF]

open access: yes, 2017
Drought, rising temperatures, and expanding human populations are increasing water demands. Many countries are extending potable water supplies by irrigating crops with wastewater.
Gan, Jay   +5 more
core   +1 more source

Carbon isotopic (C-13 and C-14) composition of synthetic estrogens and progestogens [PDF]

open access: yes, 2012
RATIONALE: Steroids are potent hormones that are found in many environments. Yet, contributions from synthetic and endogenous sources are largely uncharacterized.
Aelion   +55 more
core   +2 more sources

Profile of once-daily zonisamide as monotherapy for treatment of partial seizures in adults. [PDF]

open access: yes, 2013
Epilepsy is one of the most common neurologic disorders, affecting about 50 million people around the world. It is recognized that around 50% of patients with newly diagnosed epilepsy become seizure-free with the first drug treatment, so the choice of ...
Mula, M
core   +3 more sources

Long-term effect of antiepileptic drug switch on serum lipids and C-reactive protein. [PDF]

open access: yes, 2016
BACKGROUND: Prior studies have shown that switching patients from inducing antiepileptic drugs (AEDs) to lamotrigine, levetiracetam, or topiramate reduces serum lipids and C-reactive protein (CRP). These studies were all of short duration, and some drugs,
Chervoneva, Inna   +6 more
core   +2 more sources

Progestins Related to Progesterone and Testosterone Elicit Divergent Human Endometrial Transcriptomes and Biofunctions. [PDF]

open access: yes, 2020
Progestins are widely used for the treatment of gynecologic disorders and alone, or combined with an estrogen, are used as contraceptives. While their potencies, efficacies and side effects vary due to differences in structures, doses and routes of ...
Balayan, Shayna   +8 more
core   +1 more source

HT update: spotlight on estradiol/norethindrone acetate combination therapy [PDF]

open access: yes, 2008
The goal of postmenopausal hormone therapy is to alleviate the symptoms that are associated with the loss of estrogen. Many formulations of estrogen and progestin are available, depending on the needs and circumstances of each individual woman.
Casey, Colleen L, Murray, Christine A
core   +3 more sources

Thyroid Disease in Pregnancy [PDF]

open access: yes, 2022
Author's accepted version (postprint).This is an Accepted Manuscript of a book chapter published by Springer on 22/06/2022.Available online: https://link.springer.com/chapter/10.1007/978-3-030-98777 ...
Behboudi-Gandevani, Samira
core   +1 more source

Pharmacokinetic and Pharmacodynamic Profiles of Ethinylestradiol/Norgestimate Combination or Norethindrone upon Coadministration with Elagolix 150 mg Once Daily in Healthy Premenopausal Women [PDF]

open access: yes, 2021
Background: Two pharmacokinetic/pharmacodynamic studies were conducted to evaluate the potential drug-drug interaction between elagolix, an oral gonadotropin-releasing hormone receptor antagonist, and an oral contraceptive (ethinylestradiol [EE] 0.035 mg
Feldman, Robert
core   +1 more source

Home - About - Disclaimer - Privacy